Letter to the Editor regarding: Buprenorphine for opioid use disorder: The role of public funding in its development (by Barenie and Kesselheim, 2020).

O'Keeffe, Charles; Vocci, Frank J; Leshner, Alan

O'Keeffe, Charles; Vocci, Frank J; Leshner, Alan.

Affiliation

O'Keeffe C; Virginia Commonwealth University, United States. Electronic address: charles.okeeffe@vcuhealth.org.
Vocci FJ; Friends Research Institute, Inc., United States.
Leshner A; American Association for the Advancement of Science (Ret), United States.

Drug Alcohol Depend ; 221: 108644, 2021 04 01.

Article in En | MEDLINE | ID: mdl-33640197

Subject(s)

Buprenorphine; Opioid-Related Disorders; Buprenorphine/therapeutic use; Humans; Opiate Substitution Treatment; Opioid-Related Disorders/drug therapy; Opioid-Related Disorders/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2021 Document type: Article Country of publication: Ireland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google